Загрузка...
Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma
Partial hepatectomy is still the treatment of choice aiming at a cure for patients with hepatocellular carcinoma (HCC), provided that the patient can tolerate the treatment. For patients with multiple recurrent HCC after partial hepatectomy which cannot be treated by re-hepatectomy or local ablative...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4202381/ https://ncbi.nlm.nih.gov/pubmed/25339839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i39.14505 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|